SBC Medical Group Holdings Inc(SBC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,013 of 2,962 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
SBC Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for SBC Medical Group Holdings Inc (SBC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SBC at 58.5/100 on a 32-signal composite quality model, placing it at rank #1,013 of 2,962 stocks — the top half of the AI-ranked universe. SBC scores in the top quartile across balance sheet strength (91.2), profitability (91.1), free cash flow (88.1). Areas of concern include revenue growth (11.6) and revenue scale (22.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), SBC Medical Group Holdings Inc reports quarterly revenue of $49.2M, net income of $10.7M, an operating margin of 38.6%. Top institutional holders of SBC by reported 13-F value include Lumbard & Kellner, BlackRock, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. SBC trades on the Nasdaq exchange and files with the SEC under CIK 1930313. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SBC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SBC Medical Group Holdings Inc directly from SEC EDGAR. SBC Medical Group Holdings Inc's 13F Pro composite quality score has ranged between 36 and 59 since 2025, currently 58.5 — a stable long-term trajectory across 50 quarterly and live scoring snapshots.
Revenue
Q2 2026
$49.2M
Net Income
Q2 2026
$10.7M
Free Cash Flow
Q2 2026
$22.4M
Operating Margin
Q2 2026
38.6%
ROIC
Q2 2026
25.1%
D/E Ratio
Q2 2026
0.14
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-15.5% YoYNet Income
+9.4% YoYOperating Income
-4.0% YoYEPS (Diluted)
+4.2% YoYTotal Assets
+43.0% YoYTotal Debt
+527.6% YoYOp. Cash Flow
+19.8% YoYFree Cash Flow
+29.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $173.6M -15.5% | $205.4M +6.1% | $193.5M | — |
| Net Income | $51.0M +9.4% | $46.6M +18.4% | $39.4M | — |
| Operating Income | $67.5M -4.0% | $70.3M -0.5% | $70.7M | — |
| EPS (Diluted) | $0.50 +4.2% | $0.48 +14.3% | $0.42 | — |
| Total Assets | $380.4M +43.0% | $266.1M +2.8% | $258.8M +115.8% | $119.9M |
| Total Debt | $43.1M +527.6% | $6.9M +416.2% | $1.3M | — |
| Operating Cash Flow | $24.7M +19.8% | $20.6M -59.4% | $50.7M | — |
| Free Cash Flow | $23.3M +29.1% | $18.0M -57.2% | $42.1M | — |
Get alerted when SBC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for SBC Medical Group Holdings Inc including:
Top Institutional Holders of SBC
Lumbard & Kellner, LLC
$5.3M1,727,208 shBlackRock, Inc.
$2.8M924,002 shGEODE CAPITAL MANAGEMENT, LLC
$1.3M427,864 shCITADEL ADVISORS LLC
$445.7K144,718 shVANGUARD CAPITAL MANAGEMENT LLC
$418.2K135,783 shNORTHERN TRUST CORP
$404.1K131,204 shVANGUARD PORTFOLIO MANAGEMENT LLC
$395.1K128,295 shHillsdale Investment Management Inc.
$384.4K124,800 shSEGALL BRYANT & HAMILL, LLC
$250.4K81,307 shVANGUARD FIDUCIARY TRUST CO
$204.1K66,281 sh
| Fund | Value | Shares |
|---|---|---|
| Lumbard & Kellner, LLC | $5.3M | 1,727,208 |
| BlackRock, Inc. | $2.8M | 924,002 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.3M | 427,864 |
| CITADEL ADVISORS LLC | $445.7K | 144,718 |
| VANGUARD CAPITAL MANAGEMENT LLC | $418.2K | 135,783 |
| NORTHERN TRUST CORP | $404.1K | 131,204 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $395.1K | 128,295 |
| Hillsdale Investment Management Inc. | $384.4K | 124,800 |
| SEGALL BRYANT & HAMILL, LLC | $250.4K | 81,307 |
| VANGUARD FIDUCIARY TRUST CO | $204.1K | 66,281 |
Companies Similar to SBC
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
UTAH MEDICAL PRODUCTS INC
PUMA BIOTECHNOLOGY, INC.
SYPRIS SOLUTIONS INC
NATIONAL HEALTHCARE CORP
Pediatrix Medical Group, Inc.
biote Corp.
Prestige Consumer Healthcare Inc.
ENSIGN GROUP, INC
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put SBC on your watchlist
Track score changes the day SBC Medical Group Holdings Inc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SBC a good stock to buy?
13F Pro's AI-powered analysis of SBC Medical Group Holdings Inc (SBC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SBC are available on the SBC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SBC is classified as a small company.
Which hedge funds own SBC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SBC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of SBC Medical Group Holdings Inc's investment landscape.